VRAX Stock - Virax Biolabs Group Limited
Unlock GoAI Insights for VRAX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6,331 | $156,419 | $8,561 | N/A | $123,820 |
| Gross Profit | $-53,067 | $50,590 | $-1,365 | N/A | $-9,434 |
| Gross Margin | -838.2% | 32.3% | -15.9% | N/A | -7.6% |
| Operating Income | $-6,162,897 | $-6,496,473 | $-5,732,760 | $-1,733,680 | $-644,540 |
| Net Income | $-6,061,247 | $-6,733,537 | $-5,457,494 | $-1,708,827 | $-650,984 |
| Net Margin | -95739.2% | -4304.8% | -63748.3% | N/A | -525.8% |
| EPS | $-1.96 | $-3.36 | $-5.13 | $-1.50 | $-0.57 |
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| March 31st 2025 | H.C. Wainwright | Initiation | Buy | $3 |
Earnings History & Surprises
VRAXEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Dec 2, 2025 | — | $-0.49 | — | — |
Q3 2025 | Jul 2, 2025 | $-0.33 | — | — | — |
Q4 2024 | Nov 19, 2024 | — | $-0.89 | — | — |
Q3 2024 | Aug 20, 2024 | — | $-1.71 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-1.64 | — | — |
Q3 2023 | Sep 27, 2023 | — | $-2.58 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-1.24 | — | — |
Q3 2022 | Aug 12, 2022 | — | $-1.02 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.49 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.27 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.30 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.02 | — | — |
Latest News
Virax Biolabs Announces $5M Ordinary Shares Offering
➖ NeutralVirax Biolabs Group shares are trading higher after the company announced clinical progress and intends to report clinical data from its UK PAIS trial in 2026.
📈 PositiveVirax Biolabs Group Shares Clinical Progress, Intends To Report Clinical Data From UK PAIS Trial In 2026
➖ NeutralVirax Biolabs Completes Patient Recruitment For UK-Based, Multi-Centre Clinical Study Evaluating Performance Of ViraxImmune Assay In Detecting T Cell Dysfunction In PAIS, Including Long COVID, PTLD, And ME/CFS
📈 PositiveEXCLUSIVE: Virax BioLabs Tells Benzinga Co. Partners With Emory University On ViraxImmune Clinical Studies, Says Readies For FDA Pre-Submission Meeting In Early September
📈 PositiveFrequently Asked Questions about VRAX
What is VRAX's current stock price?
What is the analyst price target for VRAX?
What sector is Virax Biolabs Group Limited in?
What is VRAX's market cap?
Does VRAX pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to VRAX for comparison